Besides, PLS3 has been proven to be a prognostic and/or diagnostic tumor marker also in other tumor entities, e.g., non-small-cell lung cancer (NSCLC) or pancreatic ductal adenocarcinoma (PDAC) [27,28]. Here, PLS3 is linked to non-small cell lung carcinoma.